The influence of demographics, psychological factors and self-efficacy on symptom distress in colorectal cancer patients undergoing post-surgical adjuvant chemotherapy
European Journal of Oncology Nursing
Available online 13 September 2014
Abstract
Purpose
To
explore the influence of self-efficacy and demographic,
disease-related, and psychological factors on symptom distress among
Chinese colorectal cancer patients receiving postoperative adjuvant
chemotherapy.
Methods
Two-hundred
and fifty-two colorectal cancer patients who had undergone
postoperative adjuvant chemotherapy completed Chinese versions of M. D.
Anderson Symptom Inventory (MDASI-GI), Stanford Inventory of Cancer
Patient Adjustment (SICPA), and Hospital Anxiety and Depression Scale
(HADS). Associations between patients' self-efficacy and demographic,
disease-related, psychological factors and symptom distress were
examined.
Results
Patients'
overall symptom distress level was mild; MDASI median subscale scores
showed mild symptom severity and symptom interference. Anxiety and
depression were positively associated with symptom distress.
Multivariable analysis showed that more severe symptoms were associated
with age ≥60 years, female gender, suburban residence, body mass index
<18.5, and stage III cancer. Age ≥60 years, female gender, marital
status of single or divorced, and suburban residence were associated
with greater symptom interference with daily activities. Greater
self-efficacy was associated with milder symptoms severity and less
symptom interference with daily life. After adjusting for confounders,
patients with higher SICPA scores had less symptom distress.
Conclusions
Self-efficacy
is strongly associated with reduced symptom severity and symptom
interference with daily life in CRC patients. Symptom severity is
associated with age >60 years, female gender, body mass index
<18.5, suburban residence and stage III disease. Nurse-administered
self-efficacy interventions may help to improve self-efficacy and reduce
symptom distress.
No comments:
Post a Comment